2024
Arnet, I., Eickhoff, C., Sahm, L.J., Caloz, S., Mittag, M., Schulz, M. and Allemann, S.S.:
INCONCLUSIVENESS OF PSYCHOMETRIC TESTING OF MEDICATION ADHERENCE QUESTIONNAIRES.
European Journal of Clinical Pharmacology. 2024; [DOI: 10.1007/s00228-024-03684-8].
Epub April 22, 2024.
PDF PubMed
Rohr, B.S., Krohmer, E., Foerster, K.I., Burhenne, J., Schulz, M., Blank, A., Mikus, G., Haefeli, W.E.:
Time course of the interaction between oral short-term ritonavir therapy with three
factor Xa inhibitors and the activity of CYP2D6, CYP2C19, and CYP3A4 in healthy volunteers.
Clinical Pharmacokinetics. 2024; [DOI: 10.1007/s40262-024-01350-x]. Epub Feb 23, 2024.
PDF
PubMed
2023
Messner, K., Eickhoff, C., Schulz, M., Allemann, S. and Arnet,
I.:
KNOWLEDGE AND ATTITUDES OF GERMAN AND SWISS COMMUNTY PHARMACISTS TOWARDS BIOLOGICALS
AND BIOSIMILARS – A PROSPECTIVE SURVEY BEFOR AND AFTER THE COVID-19
PANDEMIC.
BMC Health Services Research. 2023; 23: 1432 [DOI: 10.1186/s12913-023-10475-x]. Epub Dec 18, 2023.
PDF PubMed
Kunz, M., Götzinger, F., Jacobs, C.M., Lauder, L., Ukena, C., Meyer, M.R., Laufs. U., Schulz, M., Böhm, M. and Mahfoud, F.:
HIDDEN Sodium IN EFFERVESCENT-TABLET dietary supplementS and over-the-counter
DRUGS – A comparative cross-sectional study.
BMJ Open. 2023; 13: e076302 [DOI: 10.1136/bmjopen-2023-076302]. Epub Nov 27, 2023.
Report in, among others: Pharmazeutische Zeitung. 2023; 168 (51-52): 3547.
PDF PubMed
Brockamp, C., Landgraf, R., Müller, U.A., Müller-Wieland, D., Petrak, F., Uebel, T.;
the National Disease Management Guideline
Group (Krueger, M., Schulz, M., et al.):
SHARED DECISION MAKING, DIAGNOSTIC EVALUATION, AND PHARMACOTHERAPY IN TYPE 2 DIABETES:
NATIONAL DISEASE MANAGEMENT GUIDELINE
[Partizipative Entscheidungsfindung, Diagnostik und medikamentöse Therapie bei Typ-2-Diabetes. Nationale VersorgungsLeitlinie].
Deutsches Arzteblatt International. 2023; 120: 804–810 [DOI: 10.3238/arztebl.m2023.0219]. Epub Nov 24,
2023.
PDF PubMed
Arnet, I., Sahm, L.J., Gregório J., Tuula, A., Krueger, M., Wurmbach, V., Kreshnik, H.,
Schulz, M. and Eickhoff, C.:
Development and validation of the 15-STARS - a novel self-report
PHARMACY-BASED questionnaire to screen for medication non-adherence.
Research in Social and Administrative Pharmacy. 2024; 20 (3):
308–320 [DOI: 10.1016/j.sapharm.2023.11.005].
Epub Nov 24, 2023.
Report in: Life Science Network.
PDF PubMed
Kerwagen,
F., Riemer, U., Wachter, R., von Haehling, S., Abdin, A., Böhm, M., Schulz, M. and Störk, S.:
impact of the COVID-19 pandemic ON IMPLEMENTATION of novel guideline-directed
medical therapies for heart failure in germany: a nationwide retrospective analysis.
The Lancet Regional Health –
Europe. 2023; 35: 100778 [DOI: 10.1016/j.lanepe.2023.100778]. Epub Nov 11, 2023.
PDF PubMed
Eickhoff, C., Müller, U., Thomas, S., Schmidt, C., Hartling, L.-S., Michael, S., Schulz, M. and Bertsche, T.:
patients’ USE OF A STANDARDIZED MEDICATION LIST – A mixed methods study.
Patient Preference and Adherence. 2023; 17: 2655–2666 [DOI: 10.2147/PPA.S427192]. Epub Oct 30, 2023.
Report in: Pharmazeutische Zeitung. 2023; 168 (46): 3166.
PDF PubMed
Schulz, M. and Laufs, U.:
Not obtaining a medication the first time it is prescribed: primary non-adherence to
cardiovascular pharmacotherapy.
Clinical Research in Cardiology. 2023; [DOI: 10.1007/s00392-023-02230-3]. Epub May
20, 2023.
Report in: Pharmazeutische Zeitung. 2023; 168 (35): 2342–2343.
PDF PubMed
Bertsche, T., Alexa J. M., Eickhoff, C. and Schulz, M.:
Self-care AND SELF-MEDICATION as central componentS of healthcare in Germany – On the way
to evidence-based pharmacy.
Exploratory Research in
Clinical and Social Pharmacy. 2023; 9 (3):
100257 [DOI: 10.1016/j.rcsop.2023.100257].
Epub April 12, 2023.
PDF PubMed
Götzinger, F., Wilke, T., Hardtstock, F., Krieger, J., Maywald, U., Kunz, M., Lauder, L., Schulz, M., Mahfoud, F. and Böhm,
M.:
association of hydrochlorothiazide treatment compared to alternative diuretics with overall
and skin cancer risk: a propensity-matched cohort study.
Journal of Hypertension. 2023; 41 (6): 926–933 [DOI: 10.1097/HJH.0000000000003414]. Epub March 10, 2023.
Report in: Pharmazeutische
Zeitung. 2023; 168 (15): 1012.
Enners, S., Gradl, G., Kieble, M., Iliescu, O., Freudewald, L., Said, A. and Schulz, M.:
Increased demand for pharmaceutical drugs containing potassium iodide in connection
with the Russia-Ukraine conflict.
Pharmazie. 2023; 78 (1): 17–19 [DOI: 10.1691/ph.2023.2541].
PDF PubMed
Gehrke-Beck, S., Petersen, M. Herrmann, W.J., Zimmermann, N., Daub, E., Seeger, J., Schulz, J., Czimmeck, C., Lauterbach, N.,
Peters, H., Kloft, C., Schulz, M., Siebenbrodt, I. and Behrend, R.:
Development of a
project for interprofessional collaboration between medical and pharmacy
students to improve medication safety in polypharmacy (PILLE).
[Entwicklung eines Lehrprojekts zur interprofessionellen Zusammenarbeit von Medizin- und Pharmaziestudierenden zur
Verbesserung der Arzneimitteltherapiesicherheit bei Polypharmazie (PILLE)].
GMS Journal for Medical Education. 2023; 40 (1): Doc3 [DOI: 10.3205/zma001585]. Epub Feb 15, 2023.
PDF PubMed
2022
Gradl, G., Kieble, M., Nagaba, J. and
Schulz, M.:
Assessment of the prescriptions of systemic antibiotics in primary dental care in Germany
from 2017 to 2021: A Longitudinal Drug Utilization StuDy.
Antibiotics.
2022; 11 (12):
1723 [DOI: 10.3390/antibiotics11121723]. Epub Nov 30, 2022.
PDF
Schulz, M., Griese-Mammen, N. and Müller, U.:
Clinical pharmacy services are reimbursed in germany – Challenges of real world
implementation remain (Commentary).
International
Journal of Clinical Pharmacy. 2023; 45 (1): 245-249 [DOI: 10.1007/s11096-022-01492-7]. Epub Nov 17, 2022.
Report in: Pharmazeutische Zeitung. 2022; 167 (48): 3264.
PDF PubMed
Moecker, R., Fuchs, A., ARMIN Study Group*, Haefeli, W.E., Weissenborn, M. and Seidling, H.M.:
ATTITUDES OF NON-PARTICIPATING GENERAL Practitioners and community pharmacists
towards
interprofessional medication management in primary care. An interview study.
International Journal of Clinical Pharmacy. 2022; 44 (6): 1380–1393 [DOI: 10.1007/s11096-022-01434-3]. Epub Oct 8, 2022.
(*Eickhoff, C., Mueller, U., Schulz, M., Braun, D., Maywald. U., Doehler, C., Maetzler, M., Auerbach, A., Kuhn, U.D.,
Moeckel, A., Honscha, C., Donner, S., Fink, S., Wagner, K., Meid, A.D., Ruff, C., Stoll, F., Wirbka, L.)
PDF PubMed
Moecker, R., Weissenborn, M., Klingenberg, A., Wirbka, L., Fuchs, A., Eickhoff, C., Mueller, U., Schulz, M.,
Kaufmann-Kolle, P., ARMIN Study Group, Haefeli, W.E. and Seidling, H.M.:
Task sharing in an interprofessional medication management program – a survey of
general practitioners and community pharmacists.
BMC Health Services Research. 2022; 22 (1): 1005 [DOI:
10.1186/s12913-022-08378-4]. Epub Aug 6, 2022.
Reports in: Pharm Ztg. DAZ.online aerztebl.de Dtsch Arztebl. 2022; 119 (35-36): A-1446.
PDF PubMed
Abdin, A., Schulz, M., Riemer, U., Hadëri, B., Wachter, R, Laufs, U., Bauersachs, J., Kindermann, I., Vukadinović, D. and
Böhm, M.:
Sacubitril/valsartan in heart failure: Efficacy and safety in and outside clinical trials.
ESC Heart Failure. 2022; 9 (6): 3737–3750 [DOI: 10.1002/ehf2.14097]. Epub Aug 3, 2022.
Report in: Cardio News 2022; 25 (11/12): 52.
PDF PubMed
Katzmann, J.L., Kieble, M., Enners, S., Böhm, M., Mahfoud, F., Laufs, U. and Schulz, M.:
Trends in ezetimibe
prescriptions as monotherapy or fixed-dose combination in
Germany 2012–2021.
Frontiers in Cardiovascular Medicine. 2022; 9:
912785 [DOI: 10.3389/fcvm.2022.912785]. Epub June 13, 2022.
Report in: Pharmazeutische Zeitung. 2022, June 16.
PubMed
Koehler, F., Störk, S. and Schulz, M.:
telemonitoring of heart failure patients is reimbursed in germany – Challenges of real
world implementation remain (Letter).
European Heart Journal – Digital Health.
2022; 3 (2): 121–122 [DOI: 10.1093/ehjdh/ztac017]. Epub April 19, 2022.
PDF
Mikus, G., Foerster, K.I., Terstegen, T., Vogt, C., Said, A., Schulz, M. and Haefeli, W.E.:
Oral drugs against COVID-19 – management of drug interactions with the
use of nirmatrelvir/ritonavir
[Orale Pharmakotherapie bei COVID-19 – Wechselwirkungsmanagement beim Einsatz von Nirmatrelvir/Ritonavir].
Deutsches Arzteblatt International. 2022; 119 (15): 263–269 [DOI: 10.3238/arztebl.m2022.0152]. Epub March 16, 2022.
PDF
PubMed
EN
Mahfoud, F., Kieble, M., Enners, S., Kintscher, U., Laufs, U., Böhm, M. and Schulz, M.:
Use of fixed-dose combination antihypertensives in Germany between 2016 AND 2020:
an example of guideline inertia.
Clinical Research in Cardiology. 2023; 112 (2): 197–202 [DOI: 10.1007/s00392-022-01993-5]. Epub Feb 27,
2022.
PDF PubMed
Reports in: Pharmazeutische Zeitung. 09.03.2022; aerzteblatt.de, 13.04.2022; MTA Dialog, 13.04.22; idw, 1204.2022
Koehler, F. and Schulz, M.:
The AMULET ménage à trois: nurse, telemedicine support, and
remote cardiologist (Editorial Comment).
European Journal of Heart Failure. 2022; 24 (3):
578–580 [DOI: 10.1002/EJHF.2437].
Epub Jan 21, 2022.
PDF PubMed
Eickhoff, C., Müller, U., Seidling, H.M., Lampert, A., Botermann, L., Strunz, A.K. and Schulz, M.:
patientS’ perception on generating medication plans in an interProfessional medication
management PROGRAM: A mixed-methods study.
Journal of
Interprofessional Care. 2022; 36 (5): 770–775 [DOI: 10.1080/13561820.2021.1994935]. Epub Jan 3, 2022.
PDF PubMed
Reports in: Pharmazeutische Zeitung. 2022; 167 (7): 408
and Deutsche Apotheker Zeitung. 2022; 162 (8): 622.
DAZ.online,
18.02.2022.
2021
Arnet, I., Verbeek, M., Almarsdóttir, A.B., Barbier, L., Clifford, R., Eickhoff, C., Hersberger, K., Huys, I., Lee, K.,
Saramunee, K., Schulz, M., Zgarrick, D., Sarnola, K.:
Community pharmacists’ preparedness for substituting biologics and dispensing
biosimilars – lessons learned from a multinational survey.
Exploratory Research in Clinical and Social
Pharmacy. 2021; 4 (Dec.): 100084 [DOI: 10.1016/j.rcsop.2021.100084].
Epub Oct 22, 2021.
PDF
Schumacher, P.M., Griese-Mammen, N., Schneider, J., Laufs, U. and Schulz, M.:
INTERDISCIPLINARY PHYSICIAN-PHARMACIST MEDICATION REVIEW FOR OUTPATIENTS WITH HEART
FAILURE:
A SUBANALYSIS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL.
Frontiers in Pharmacology. 2021; 12: 712490 [DOI: 10.3389/fphar.2021.712490]. Epub Sep 7, 2021.
PDF PubMed
Enners, S., Gradl, G., Kieble, M., Böhm, M., Laufs, U. and Schulz, M.:
UTILIZATION OF DRUGS WITH REPORTS ON POTENTIAL EFFICACY OR HARM ON COVID-19 BEFORE, DURING, AND
AFTER THE FIRST PANDEMIC WAVE.
Pharmacoepidemiology and Drug Safety. 2021; 30 (11): 1493–1503 [DOI: 10.1002/pds.5324]. Epub July 9, 2021.
Among the Top Cited Articles 2021–2022.
Report in: Pharmazeutische Zeitung. 2021; 166 (31): 2278.
PDF PubMed
Schumacher, P.M., Becker, N., Griese-Mammen, N., Tsuyuki, R.T., Koshman, S.K., McDonald, M.A., Bouvy, M., Rutten, F.H.,
Laufs, U., Böhm, M. and Schulz, M.:
THE EVIDENCE FOR PHARMACIST CARE IN OUTPATIENTS WITH HEART FAILURE:
A SYSTEMATIC REVIEW AND META-ANALYSIS.
ESC Heart Failure. 2021; 8 (5):
3566–3576 [DOI: 10.1002/ehf2.13508]. Epub July 8, 2021.
Report in Pharmazeutische Zeitung. 2021; 166 (37): 2679–2680.
PDF PubMed
Gradl, G., Werning, J., Enners, S., Kieble, M. and Schulz, M.:
Quality appraisal of AMBULATORY oral cephalosporin and fluoroquinolone use in
the 16 German federal states from 2014–2019.
Antibiotics. 2021; 10 (7): 831 [DOI:
10.3390/antibiotics10070831]. Epub July 8, 2021.
Report in Pharmazeutische Zeitung. 2021; 166 (32): 2336.
PDF PubMed
Said, A., Freudewald, L., Parrau, N., Ganso, M. and Schulz, M.:
Pharmacists’ perception of educational material TO IMPROVE PATIENT SAFETY:
A CROSS-SECTIONAL sTuDy on practices and awareness IN GERMANY.
Medicine. 2021; 100 (11): e25144 [DOI: 10.1097/MD.0000000000025144]. Epub March 19, 2021.
PDF PubMed
Rüsenberg, R., Baumgarten, A., Mauss, S., Gradl, G., Schulz, M., Bartmeyer, B., Kollan, C. and Schmidt, D.:
WIE WIRKEN GENERIKAQUOTEN? EINE ANALYSE AM BEISPIEL HIV
[How do generic quotas work? An analysis using HIV
infection as an e example].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021; 64 (5): 625–634.
[DOI: 10.1007/s00103-021-03312-1]. Epub April 14, 2021.
PDF PubMed
2020
Moorkens, E., Barcina, T., Vulto, A.G., Schulz, M., Gradl, G., Enners, S., Selke,
G., Huys, I. and Simoens, S.:
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany.
Pharmaceuticals. 2020; 13 (10): 324 [DOI: 10.3390/ph13100324]. Epub Oct 21, 2020.
PDF PubMed
Rudolph, U., Enners, S., Kieble, M., Mahfoud, F., Böhm, M., Laufs, U. and Schulz, M.:
IMPACT of Angiotensin Receptor Blocker Product Recalls ON ANTIHYPERTENSIVE PRESCRIBING in Germany.
Journal of Human Hypertension. 2020; 35: 903–911 [DOI:
10.1038/s41371-020-00425-z]. Epub Oct 14,
2020.
PDF PubMed
Schulz, M., Griese-Mammen, N., Schumacher,, P.M., Strauch, D., Freudewald, L., Said, A., Tsuyuki, R.T., Laufs, U.,
Kintscher, U., Böhm, M. and Mahfoud, F.:
Development and Implementation of Blood Pressure Screening and Referral Guidelines
for German Community Pharmacists.
Journal of Clinical Hypertension. 2020; 22 (10): 1807–1816 [DOI: 10.1111/JCH.14020]. Epub Aug 30, 2020.
JCH PDF Suppl Fig S1 Suppl Fig S3 PubMed
Garcia Cardenas, V., Rossing, C., Fernandez-Llimos, F., Schulz, M., Tsuyuki, R.T., Bugnon, O., Tonin, F. and Benrimoj,
S.I.:
PHARMACY PRACTICE RESEARCH – A CALL TO ACTION.
Research in Social and Administrative Pharmacy. 2020; 16 (11): 1602–1608 [DOI: 10.1016/j.sapharm.2020.07.031].
Epub Aug 4, 2020.
RSAP PubMed
Mahfoud, F., Kieble, M.,
Enners, S., Werning, J., Laufs, U., Millenaar, D., Böhm, M., Kintscher, U. and Schulz, M.:
ROTE-HAND-BRIEF ZU HYDROCHLOROTHIAZID UND VERORDNUNG VON ANTIHYPERTENSIVA
[„Dear Doctor“ warning letter (Rote-Hand-Brief) on hydrochlorothiazide and antihypertensive prescribing].
Deutsches Ärzteblatt
International. 2020; 117: 687–688 [DOI: 10.3238/arztebl.2020.0687].
PDF PubMed
Schulz,
M., Griese-Mammen, N., Schumacher, P.M., Anker, S.D., Koehler, F., Ruckes, C., Rettig-Ewen, V., Wachter, R.,
Trenk, D., Böhm, M. and Laufs, U.:
THE IMPACT OF PHARMACIST/PHYSICIAN CARE ON QUALITY OF LIFE IN ELDERLY HEART FAILURE PATIENTS:
RESULTS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL.
ESC Heart Failure. 2020; 7 (6):
3310–3319 [DOI:10.1002/ehf2.12904].
Epub July 23, 2020.
PDF PubMed
Schulz, M., Schmoldt,
A., Andresen-Streichert, H. and Iwersen-Bergmann, S.:
REVISITED: THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 1,100 DRUGS AND
OTHER XENOBIOTICS.
Critical
Care. 2020; 24 (1): 195 [DOI: 10.1186/s13054-020-02915-5]. Epub May 6, 2020
[12k Article Accesses as of 18 November 2023].
PDF Suppl. File
PubMed
2019
Schönfeld, T., Heineman, A., Schulz, M., Gradl, G., Andresen-Streichert, H., Müller, A. and
Iwersen-Bergmann, S.:
POST-MORTEM ANALYSIS OF PRESCRIPTION OPIOIDS - A FOLLOW-UP EXAMINATION BY LC-MS/MS WITH
FOCUS ON FENTANYL.
Forensic Science International. 2019; 305: 109970 [DOI: 10.1016/j.forsciint.2019.109970]. Epub Oct 9, 2019.
Forensic Sci Int PubMed
Said, A., Ganso, M., Freudewald, L. and Schulz, M.:
Trends in dispensing oral emergency contraceptives and safety issues:
a survey of German community pharmacists.
International Journal of Clinical Pharmacy. 2019; 41 (6): 1499–1506; [DOI: 10.1007/s11096-019-00911-6]. Epub Sep 28, 2019.
IJCP PDF Suppl. Material PubMed
Hofmann, G. A.,
Gradl, G., Schulz, M., Haidinger, G., Tanew, A. and Weber, B.:
The frequency of photosensitizing drug dispensings in Austria and Germany: A coRRELATION
WITH THEIR PHOTOSENSITIZING POTENTIAL BASED ON PUBLISHED LITERATURE.
Journal of the European
Academy of Dermatology and Venereology. 2020; 34 (3): 589–600 [DOI:
10.1111/jdv.15952].
Epub Sep 14, 2019.
PDF PubMed Wiley
Schulz, M., Griese-Mammen, N., Böhm, M. and Laufs, U.:
Letter on ‘PHARMACY-BASED INTERDISCIPLINARY INTERVENTION FOR PATIENTS WITH CHRONIC HEART FAILURE:
RESULTS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL': REPLY.
European Journal of Heart Failure. 2020; 22 (3): 565–566 [DOI: 10.1002/ejhf.1613]. Epub Sep 16, 2019.
Schulz, M., Griese-Mammen, N.,
Anker, S.D., Koehler, F., Ihle, P., Ruckes, C., Schumacher, P.M., Trenk, D., Böhm, M. and Laufs, U.
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure:
results of the PHARM-CHF randomized controlled trial.
European Journal of Heart Failure. 2019; 21 (8): 1012–1021 [DOI: 10.1002/ejhf.1503). Epub May 25, 2019.
PubMed
EJHF PDF Suppl. Material
Eickhoff, C., Müller, U., Strunz, A.K., Seidling, H.M.,
Lampert, A., Felberg, M., Breiholz, S., Klintworth, D. and Schulz, M.:
Das Projekt PRIMA -
Elektronische Erstellung und Aktualisierung von Medikationsplänen als
gemeinsame Aufgabe von Ärzten und Apothekern
[The PRIMA project - electronically-supported physician-pharmacist co-operation to generate
and update medication plans in Germany].
Deutsche Medizinische Wochenschrift 2019;
144 (18): e114–e120 [DOI: 10.1055/a-0859-5862]. Epub March 29, 2019.
PubMed
PDF
Ihle, P., Krueger, K., Schubert, I. Griese-Mammen, N.,
Parrau, N., Laufs, U. and Schulz, M.:
Comparison of different strategies to measure medication adherence via claims data in patients
with chronic heart failure.
Clinical Pharmacology & Therapeutics. 2019; 106 (1): 211–218 [DOI: 10.1002/cpt.1378]. Epub Jan 29, 2019.
PubMed
PDF
Breiholz, S., Griese-Mammen, N., Krueger, K., Schaefer, M. and Schulz, M.:
Acceptance of a Medication Refill Reminder Service in GERMAN Community Pharmacy Practice.
Pharmazie. 2019; 74 (3): 186–190 [DOI: 10.1691/ph.2019.8669].
PubMed
Katzman, J., Mahfoud, F., Böhm, M., Schulz, M. and Laufs, U.:
ASSOCIATION OF MEDICATION ADHERENCE AND DEPRESSION WITH CONTROL OF LDL CHOLESTEROL AND BLOOD PRESSURE IN PATIENTS WITH HIGH CARDIOVASCULAR
RISK.
Patient Preference and Adherence. 2019; 13: 9–19. [DOI: 10.2147/PPA.S182765]. Epub Dec 18, 2018.
PubMed PDF
2018
Said, A., Goebel, R., Ganso, M., Zagermann-Muncke, P. and Schulz, M.:
Drug shortages may compromise patient safety: results of a survey of the reference pharmacies of
the Drug Commission of German Pharmacists.
Health Policy. 2018; 122 (12):1302–1309 [DOI: 10.1016/j.healthpol.2018.09.005]. Epub Sep 13, 2018.
PubMed
Gradl, G., Teichert, M., Kieble, M., Werning, J. and Schulz, M.:
COMPARING OUTPATIENT ORAL ANTIBIOTIC USE IN GERMANY AND THE NETHERLANDS FROM 2012 TO 2016.
Pharmacoepidemiology and Drug Safety. 2018; 27 (12): 1344–1355 [DOI: 10.1002/pds.4643]. Epub Sep 28, 2018.
PubMed PDF
Müller, U., Schulz, M., and Mätzler, M.:
Elektronisch unterstützte Kooperation ambulant tätiger Ärzte und Apotheker zur Verbesserung
der Arzneimitteltherapiesicherheit. Die Arzneimittelinitiative Sachsen-Thüringen (ARMIN)
[Electronically supported co-operation of physicians and pharmacists to improve medication safety in the ambulatory setting. The “Arzneimittelinitiative Sachsen-Thüringen”
(ARMIN)].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018; 61
(9): 1119–1128
[DOI: 10.1007/s00103-018-2780-5]. Epub July
30, 2018.
PubMed
PDF
Dormann, H., Maas, R., Eickhoff, C., Müller, U., Schulz, M., Brell, D. and Thürmann, P.:
ERPROBUNG DES BUNDESEINHEITLICHEN MEDIKATIONSPLANS IN DER PRAXIS: DIE PILOTPROJEKTE
METROPOLMEDIPLAN 2016, MODELLREGION ERFURT UND PRIMA
[Testing the standardized medication plan: the pilot projects MetropolMediplan 2016, model region Erfurt and PRIMA].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018; 61
(9): 1093–1102
[DOI: 10.1007/s00103-018-2789-9]. Epub July 25,
2018.
Laufs, U., Griese-Mammen, N., Krueger, K., Wachter, A., Anker, S.D., Koehler, F.,
Rettig-Ewen, V., Botermann, L., Strauch, D.,
Trenk, D., Böhm, M. and Schulz, M.:
PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial and
results of the pilot study.
European Journal of Heart Failure. 2018; 20 (9):
1350–1359 [DOI: 10.1002/ejhf.1213]. Epub May 30,
2018.
Weißenborn, M., Schulz, M., Kraft, M., Haefeli, W.E. and Seidling, H.M. :
Potentielle Erfolgsindikatoren für die Durchführung von Projekten zur Arzt-Apotheker-Zusammenarbeit – eine systematische
Übersicht
[Potential benchmarks for successful interdisciplinary collaboration projects in Germany: a systematic review].
Gesundheitswesen. 2019;
81 (12): 1057–1068
[DOI: 10.1055/a-0592-7184]. Epub June 21, 2018.
PubMed Gesundheitswesen
2017
Felberg, M., Reckers, K., Schulz, M. and Scherneck, S.:
DER DIABETOLOGISCH QUALIFIZIERTE APOTHEKER DDG. EVALUATION EINER PRAXISORIENTIERTEN
INTENSIV-FORTBILDUNG
[Community pharmacist care of patients with diabetes: opportunities and limitations].
Medizinische
Monatsschrift für Pharmazeuten. 2017; 40 (11): 496–501.
Botermann, L., Wachter, A., Monzel, K., Krueger, K., Ewen, S., Mahfoud, F., Griese-Mammen, N.,
Schulz, M. and Laufs, U.:
Do patients with diabetes type 2 or chronic heart failure understand a medication plan?
Pharmazie. 2017; 72 (12): 764–768 [DOI: 10.1691/ph.2017.7773].
PubMed
Krueger, K., Griese-Mammen, N., Schubert, I., Kieble, M., Botermann, L., Laufs, U., Kloft, C.
and Schulz, M.:
IN SEARCH OF A STANDARD WHEN ANALYZING
MEDICATION ADHERENCE IN PATIENTS WITH HEART FAILURE
USING CLAIMS DATA: A SYSTEMATIC REVIEW.
Heart Failure
Reviews. 2018; 23 (1): 63–71 [DOI:
10.1007/s10741-017-9656-x]. Epub Oct 9, 2017.
PubMed Full text
Schulz, M. et al. / BÄK, KBV, AWMF, AMK et al. (eds.):
National Disease Management Guideline CHRONIC HEART FAILURE
(Nationale VersorgungsLeitlinie [NVL] chronische Herzinsuffizienz).
2nd
edition 2017.
2016
Schulz, M., Goebel, R., Schumann, C. and Zagermann-Muncke, P.:
Non-prescription dispensing of emergency oral contraceptives: Recommendations from the
German Federal Chamber of Pharmacists [Bundesapothekerkammer].
Pharmacy Practice (Granada). 2016; 14 (3): 828 [DOI: 10.18549/PharmPract.2016.03.828].
PubMed Full
text
Custodis, F., Rohlehr, F., Wachter, A., Böhm, M., Schulz, M. and Laufs, U.:
Medication knowledge of patients hospitalized for heart failure at
admission and after discharge.
Patient Preference and Adherence. 2016; 10: 2333–2339 [DOI: 10.2147/PPA.S113912].
PubMed
Full text
Gradl, G., Krieg, E.-M. and Schulz, M.:
EVALUATION OF PHARMACEUTICAL CONCERNS IN GERMANY: FREQUENCY AND POTENTIAL REASONS.
Pharmacy Practice (Granada). 2016; 14 (3): 786 [DOI: 10.18549/PharmPract.2016.03.786].
PubMed Full text Suppl. Material
Schulz, M.,
Krueger, K., Schuessel, K., Friedland, K., Laufs, U., Müller, W.E. and Ude, M.:
MEDICATION ADHERENCE AND Persistence according to DIFFERENT antihypertensive drug classES:
A RETROSPECTIVE cohort STUDY of 255,500 patients.
International Journal of Cardiology. 2016; 220: 668–676 [DOI:
10.1016/j.ijcard.2016.06.263]. Epub June 29, 2016.
PubMed IJC Full text
Ganso, M., Goebel, R., Melhorn, S., Schrenk, D. and Schulz, M.:
Lipidpneumonie durch LIPID-haltige Nasensprays und -tropfen
[Lipoid pneumonia associated with lipid-containing nasal sprays and nose
drops].
Laryngo-Rhino-Otologie. 2016; 95 (8): 534–539 [DOI: 10.1055/s-0042-108445]. Epub Aug 9, 2016.
PubMed Full text
Botermann, L., Monzel, K., Krueger, K., Eickhoff, C., Wachter, A., Kloft, C., Laufs, U. and
Schulz, M.:
evaluating PATIENTS’ COMPREHENSIBILITY of a standardized medication plan.
European Journal of Clinical Pharmacology. 2016; 72 (10):
1229–1237 [DOI: 10.1007/s00228-016-2082-5]. Epub June 15, 2016.
PubMed EJCP
Botermann, L., Krueger, K., Eickhoff, C., Kloft, C. and
Schulz, M.:
PATIENT’S HANDLING OF A STANDARDIZED MEDICATION PLAN: A PILOT STUDY AND METHOD DEVELOPMENT.
Patient Preference and Adherence. 2016; 10: 621–630 [DOI: 10.2147/PPA.S96431]. Epub April 22, 2016.
PubMed Full text
van Mil, J.W.F., Westerlund, T., Brown, L., Chen, T.F., Henman, M., Hersberger, K.,
McElnay, J. and Schulz,
M.:
MEDICAL CARE AND DRUG-RELATED PROBLEMS: DO DOCTORS AND PHARMACISTS SPEAK THE SAME LANGUAGE?
International Journal of Clinical Pharmacy. 2016; 38 (2): 191–194, erratum 195; [DOI: 10.1007/s11096-016-0249-x].
Epub Jan 21, 2016.
PubMed
Full text Erratum
2015
Krueger, K., Botermann, L., Schorr, S.G., Griese-Mammen, N., Laufs, U. and Schulz,
M.:
Age-related
medication adherence in patients with chronic heart failure: a systematic literature review.
Int. J.
Cardiol. 2015; 184: 728-735 [DOI: 10.1016/j.ijcard.2015.03.042]. Epub
March 4, 2015.
Abstract IJC PubMed
Full text Suppl. material
Schulz, M., Meins, J., Diemert, S., Zagermann-Muncke, P., Goebel, R., Schrenk, D., Schubert-Zsilavecz, M. and Abdel-Tawab, M.:
Detection of pyrrolizidine alkaloids in German licensed herbal medicinal teas.
Phytomedicine. 2015; 22 (6): 648-656 [DOI: 10.1016/j.phymed.2015.03.020]. Epub April 29, 2015.
ScienceDirect PubMed Full text
Hansen, K., Schüssel, K., Kieble, M., Werning, J., Schulz, M., Friis, R., Pöhlau, D., Schmitz, N. and Kugler, J.:
Adherence to disease modifying drugs among patients with multiple sclerosis in Germany: A retrospective cohort
study.
PLoS One 2015; 10 (7): e0133279 [DOI:
10.1371/journal.pone.0133279.]. Epub July 27, 2015.
PubMed
Full
text
2014
Saverno, K., Gothe, H., Schüssel, K., Biskupiak, J.E., Schulz, M., Siebert, U. and
Brixner, D.:
Consideration of International Generic Distribution Policies on Patient Outcomes in the United States and Germany.
Pharmazie. 2014; 69 (3): 238-240 [DOI:
10.1691/ph.2014.3786].
PubMed
Schorr, S.G., Eickhoff, C., Feldt, S., Hohmann, C. and Schulz, M.:
EXPLORING THE potential impact of hospital ward-based pharmacy interns on drug safety.
Pharmazie. 2014; 69 (4): 316-320 [DOI:
10.1691/ph.2014.3848].
PubMed
Ewen, S., Baumgarten, T., Rettig-Ewen, V., Mahfoud, F., Griese-Mammen, N., Schulz, M., Böhm, M. and
Laufs, U.:
Analyses of drugs
stored at home by elderly patients with chronic heart failure.
Clin. Res. Cardiol. 2015;
104 (4): 320-327 [DOI:
10.1007/s00392-014-0783-2]. Epub November 6, 2014.
PubMed
Full text
Fikenzer, K., Knoll, A., Fischer, D., Schulz, M., Böhm, M. and Laufs, U.:
Chronische Herzinsuffizienz: Teufelskreis aus geringer Einnahmetreue von Medikamenten und kardialer
Dekompensation.
[Poor medication adherence and worsening heart failure - a vicious circle].
Dtsch. Med. Wochenschr.
2014; 139 (47): 2390-2394
[DOI: 10.1055/s-0034-1387391]. Epub November 12, 2014.
PubMed Full
text
2013
Ude, M., Leuner, K., Schüssel, K., Schulz, M. and Müller, W.E.:
ADHERENCE TO ANTIHYPERTENSIVES: FEASIBILITY OF TWO SELF-REPORT INSTRUMENTS TO INVESTIGATE MEDICATION-TAKING BEHAVIOUR IN GERMAN COMMUNITY PHARMACIES.
Int. J. Pharm. Pract. 2013; 21 (3): 169-177 [DOI:
10.1111/j.2042-7174.2012.00248.x]. Epub October 29, 2012.
PubMed
Nicolas, A., Eickhoff, C.,
Griese, N. and Schulz, M.:
drug-related problems in prescribed medicines IN GermanY at the time OF dispensING.
Int. J. Clin. Pharm. 2013; 35 (3): 476-482 [DOI:
10.1007/s11096-013-9769-9]. Epub April 20, 2013.
PubMed
Czeche, S., Schüssel, K., Franzmann, A., Burkart, M. and Schulz, M.:
DOSAGE STRENGTH IS ASSOCIATED WITH MEDICATION PERSISTENCE WITH GINGKO BILOBA DRUG PRODUCTS.
BMC Complement. Altern. Med. 2013; 13 (1): 278 [DOI: 10.1186/1472-6882-13-278]. Epub October 24, 2013.
PubMed
Full text PDF
2012
Quinzler, R., Ude, M., Franzmann, A., Feldt, S., Schüssel, K., Leuner, K., Müller,
W.E., Dippel.F.-W. and Schulz, M.:
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in type 2 diabetic patients: comparison of insulin glargine with NPH
insulin.
Int. J. Clin. Pharmacol. Ther. 2012; 50 (1): 24–32.
PubMed
Eickhoff, C., Hämmerlein, A., Griese, N. and Schulz, M.:
Nature and frequency of drug-related problems in self-medicatioN (OVER-THE-COUNTER DRUGS) in daily community pharmacy practice in Germany.
Pharmacoepidemiol. Drug Saf. 2012; 21 (3): 254-260 [DOI:
10.1002/pds.2241]. Epub September 28, 2011.
PubMed
Hohmann, C., Eickhoff, C., Radziwill, R. and Schulz, M.:
Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals:
A multicenter evaluation involving pharmacy interns.
Infection 2012; 40 (2): 131–137 [DOI: 10.1007/s15010-011-0204-7]. Epub October 15, 2011.
PubMed
Feldt, S., Schüssel, K., Quinzler, R., Franzmann, A., Czeche, S., Ludwig, W.-D. and Schulz, M.:
INCIDENCE OF THYROID HORMONE THERAPY IN PATIENTS TREATED WITH SUNITINIB OR SORAFENIB: A COHORT STUDY.
Eur. J. Cancer 2012; 48 (7): 974-981
[DOI:10.1016/j.ejca.2012.01.036]. Epub February 28, 2012.
PubMed Full text
Schulz, M., Iwersen-Bergmann, S., Andresen, H. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD
CONCENTRATIONS OF NEARLY 1,000 DRUGS AND OTHER XENOBIOTICS.
Critical Care 2012; 16: R136 [DOI:10.1186/cc11441]. Epub July 26, 2012.
[28k Article Accesses].
PubMed
Full text (including suppl. material) Additional file 1
2011
Krüger, M., Griese, N. and Schulz, M.:
Medikationsmanagement für Menschen mit Diabetes.
[Home medication review for patients with diabetes].
Diabetes Stoffw. Herz 2011; 20 (4): 219–226.
Online
Hohmann, C., Eickhoff, C., Kämmerer, W. and Schulz, M.:
Compliance with antithrombotic guidelines in surgery patients in German hospitals: A multicenter study involving pharmacy interns.
Clin. Appl. Thromb. Hemost. 2012; 18 (3): 299–304 [DOI: 10.1177/1076029611412368]. Epub July 6, 2011.
PubMed
Ude, M., Schüssel. K.,
Quinzler, R., Leuner, K., Müller, W.E. and Schulz, M.:
Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a
retrospective Study using the DAPI database.
J. Hypertens. 2011; 29 (9): 1837–1845 [DOI: 10.1097/HJH.0b013e32834942be]. Epub July 6, 2011.
PubMed
Hohmann, C. Eickhoff, C., Klotz, J.M., Schulz, M. and Radziwill, R.:
DEVELOPMENT OF A CLASSIFICATION SYSTEM FOR DRUG-RELATED PROBLEMS IN THE HOSPITAL SETTING (APS-Doc) AND ASSESSMENT OF THE INTER-RATER RELIABILITY.
J. Clin. Pharm. Ther. 2012; 37 (3): 276–281 [DOI: 10.1111/j.1365-2710.2011.01281.x]. Epub July 26, 2011.
PubMed
Laufs, U., Böhm, M., Kroemer, H.K., Schüssel, K., Griese, N. and Schulz, M.:
Strategien zur Verbesserung der Einnahmetreue von Medikamenten.
[Strategies to Improve Medication Adherence].
Dtsch. Med. Wochenschr. 2011; 136 (31-32): 1616–1621. Epub August 1, 2011.
PubMed
2010
Hämmerlein, A., Müller, U. and Schulz, M.:
VERSORGUNGSMANAGEMENT FÜR MENSCHEN MIT ASTHMA – EINBINDUNG DER APOTHEKER
[Involving pharmacists in the management of asthma
patients].
Z. Evid. Fortbild. Qual. Gesundh. wesen 2010; 104 (2): 92–98 [DOI : 10.1016/j.zefq.2009.07.007].
PubMed
Hämmerlein, A., Müller, U. and Schulz M.:
Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients.
J. Eval. Clin. Pract. 2011; 17 (1): 61–70 [DOI: 10.1111/j.1365-2753.2010.01369.x]. Epub Aug 30, 2010.
PubMed
2009
Hämmerlein, A. and Schulz, M.:
Co-authors of the German National Disease Management Guideline (Nationale VersorgungsLeitlinie (NVL)) ASTHMA, 2nd ed. 2009.
Eds.: Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
(AWMF).
Revision in: Dtsch. Ärztebl. 2011; 108 (11): A-596 / B-484 / C-484.
NVL Asthma
2008
Schüssel, K., Quinzler, R., Czeche, S. and Schulz, M.:
AKTUELLE VEORDNUNGEN VON COX-2-HEMMERN IN DEUTSCHLAND
[Contemporary precriptions of COX-2 inhibitors in Germany].
Internist. Praxis 2008; 48 (4): 837–850.
Full
text
2007
Gerdemann, A., Griese, N. and Schulz, M.:
PHARMACY INTERNS ON THE WARD – A PILOT STUDY.
Pharm. World Sci. 2007; 29 (1): 34–38 (DOI: 10.1007/s11096-005-5044-z].
PubMed
Rajska-Neumann, A., Wieczorowska-Tobis, K., Schulz, M., Breborowicz, A., Grzeskowiak, E. and Oreopoulos D.G.:
Duplicate use of angiotensin-converting enzyme (ACE) inhibitors in a community-dwelling elderly population in Poland.
Arch. Gerontol. Geriatr. 2007; 44 (Suppl. 1): 295–301.
PubMed
Bertsche, T., Hämmerlein, A. and Schulz, M.:
GERMAN NATIONAL DRUG INFORMATION SERVICE: USER SATISFACTION AND POTENTIAL POSITIVE PATIENT OUTCOMES.
Pharm. World. Sci. 2007; 29 (3): 167–172 [DOI: 10.1007/s11096-006-9041-7].
PubMed
Hämmerlein, A., Griese, N., and Schulz, M.:
Survey of Drug-related
Problems Identified by Community Pharmacies.
Ann. Pharmacother. 2007; 41 (11): 1825–1832 [DOI: 10.1345/aph.1K207].
PubMed
2006
Eickhoff, C. and Schulz, M.:
PHARMACEUTICAL CARE IN COMMUNITY PHARMACIES: PRACTICE AND RESEARCH IN GERMANY.
Ann. Pharmacother. 2006; 40 (4): 729–735 [DOI: 10.1345/aph.1G458].
PubMed
Schulz, M.,
Graefe, T., Stuby, K., Andresen, H., Kupfermann, N. and Schmoldt, A.:
Case report: Acute unintentional carbachol intoxication.
Critical Care 2006; 10: R84 [DOI:10.1186/cc4937].
Full text
Schulz, M., Hämmerlein, A., Hinkel, U., Weis, G. and Gillissen, A.:
SAFETY AND USAGE PATTERN OF AN OVER-THE-COUNTER AMBROXOL COUGH SYRUP:
A COMMUNITY PHARMACY-BASED COHORT STUDY.
Int. J. Clin. Pharmacol. Ther. 2006; 44 (9): 409–421.
PubMed
Müller, U., Hämmerlein, A., Casper, A. and Schulz, M.:
EVALUATION DER DURCHFÜHRUNG VON GLUKOSESELBSTKONTROLLEN IN APOTHEKEN (EDGAr)
[Evaluation of self-monitoring of blood glucose in pharmacies - EDGAr].
Diabetes Stoffw. Herz 2006; 15
(4): 9–17.
Müller, U., Hämmerlein, A., Casper, A. and Schulz, M.:
COMMUNITY PHARMACY-BASED INTERVENTION TO IMPROVE
SELF-MONITORING OF BLOOD GLUCOSE IN TYPE 2 DIABETIC PATIENTS.
Pharmacy Practice (Granada). 2006; 4 (4): 195–203.
Full
text
Schuessel, K. and Schulz, M.:
PRESCRIBING OF COX-2-INHIBITORS IN GERMANY AFTER SAFETY WARNINGS AND MARKET WITHDRAWALS.
Pharmazie. 2006; 61
(10): 878–886.
PubMed
Van Mil, J.W.F. and Schulz, M.:
A review of Pharmaceutical Care in Community Pharmacy in Europe.
Harvard Health Policy Review. 2006; 7 (1): 155–168.
Full
text
2005
Berger, K, Eickhoff, C. and Schulz, M.:
Counselling quality in community pharmacies:
Implementation of the pseudo customer methodology in Germany.
J. Clin. Pharm. Ther. 2005; 30 (1): 45–57.
PubMed
Mangiapane, S., Schulz, M., Mühlig, S., Ihle, P., Schubert, I. and Waldmann, H.-C.:
COMMUNITY PHARMACY-BASED PHARMACEUTICAL CARE FOR ASTHMA PATIENTS.
Ann. Pharmacother. 2005; 39 (11): 1817–1822.
PubMed
2004
Van Mil, J.W.F., Schulz, M. and Tromp, Th.F.J.:
PHARMACEUTICAL CARE, EUROPEAN DEVELOPMENTS IN CONCEPTS, IMPLEMENTATION, TEACHING, AND RESEARCH: A REVIEW.
Pharm. World Sci. 2004; 26 (6): 303–311.
PubMed
2003
Hauner, H., Maxion-Bergemann, S., Müller, E., Schulz, M., Huppertz, E. and Bergemann, R.:
DMP DIABETES MELLITUS: SIMULATION DER BEHANDLUNGSERGEBNISSE VERSCHIEDENER LEITLINIEN. Ein neues Diabetes
mellitus Modell (DMM).
[Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model
(DMM)].
Dtsch. Med. Wochenschr. 2003; 128 (21): 1167–1172.
PubMed
Schulz, M. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 800 DRUGS AND OTHER XENOBIOTICS.
Pharmazie. 2003; 58
(7): 447–474.
PubMed
2002
Azodi, K., Himstedt, S., Hinrichs, A., Krüger, M., Schrader, S. and Schulz, M.:
TESTING OF THE READABILITY OF PACKAGE LEAFLETS AS AN INITIAL STEP UNDER THE PHARMACEUTICAL CARE INITIATIVE TOWARDS INCREASING THE SAFETY OF MEDICINAL PRODUTCS.
Pharm. Ind. 2002; 64 (11): 1119–1125.
2001
Schulz, M., Schmoldt, A., Donn, F. and Becker, H.:
LACK OF METHEMOGLOBINEMIA WITH FLUTAMIDE.
Ann. Pharmacother. 2001; 35 (1): 21–25.
PubMed
Brockmeyer, R., Steindl, L., Behrens, I., Gnekow, S., Verheyen, F. and Schulz, M.:
Testing of the readability of package inserts at a community pharmacy.
Pharm. Ind. 2001; 63 (2): 114–119.
Online
Schulz, M., Verheyen, F., Mühlig, S., Müller, J.M., Mühlbauer, K., Knop-Schneickert, E., Petermann, F. and Bergmann, K.-C.:
PHARMACEUTICAL CARE SERVICES FOR ASTHMA PATIENTS: A CONTROLLED INTERVENTION STUDY.
J. Clin. Pharmacol. 2001; 41 (6): 668–676.
PubMed
Reports in, among
others: Pharm. J. 2001; 267 (14 July): 43 and FIP News 2001; 2 (9): 2.
2000
Stein, S., Schmoldt, A. and Schulz, M.:
FATAL INTOXICATION WITH MELPERONE.
Forensic Sci. Int. 2000; 113 (1-3):
409–413.
PubMed
Seibt, K., Schulz, M. and Hensel, F.J.:
MEINUNGEN UND EINSTELLUNGEN ZUM THEMA IMPFEN BEI NIEDERGELASSENEN ÄRZTEN, OFFIZINAPOTHEKERN UND IHREM PERSONAL SOWIE AKTUELLER IMPFSTATUS DIESER GRUPPEN
[Opinions and attitudes on the topic of vaccination of established physicians, pharmacists and their personnel and current vaccination status of these groups].
Gesundheitswesen 2000; 62 (7): 376–382.
PubMed
1999
Iwersen-Bergmann, S., Schmoldt, A., Püschel, K. and Schulz, M.:
VERGIFTUNGS- UND TODESFÄLLE DURCH SUBSTITUTIONSMITTEL IM UMFELD VON SUBSTITUIERTEN DROGENKONSUMENTEN
[Fatal and non-fatal poisonings with substitute drugs in the environment of substituted addicts].
Rechtsmedizin 1999; 9 (3): 90–93.
Abstract
Abstract
(German)
1997
Schulz, M.
and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 500 DRUGS.
Pharmazie 1997; 52 (12):
895–911.
PubMed
1996
Scholz, J., Steinfath, M. and Schulz, M.:
CLINICAL PHARMACOKINETICS OF ALFENTANIL, FENTANYL, AND SUFENTANIL: AN UPDATE.
Clin. Pharmacokinet.
1996; 31 (4): 275–292.
PubMed
1995
Scholz, J., Schulz, M., Steinfath, M., Höver, S. and Bause, H.:
FLUCONAZOLE IS REMOVED BY CONTINUOUS VENOVENOUS HEMOFILTRATION IN A
LIVER TRANSPLANT PATIENT.
J. Mol. Med. 1995; 73 (3): 145–147.
PubMed
Schmoldt, A., Sagowski, C., Iwersen, S. and Schulz, M.:
HEMMUNG DER ADH-AKTIVITÄT DES MAGENS DURCH H2-REZEPTORENBLOCKER
[Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists].
Rechtsmedizin 1995; 5: 73–77.
Fox, J.M., unter Mitarbeit von Menges, K., Coper, H., Doenicke, A., Ferner, U.J., Gaertner, H.J., Hoffmeister, F., Janke, W., Janzen, R.W.C., Kanowski, S., Kreiskott, H., Müller-Oerlinghausen,
B., Netter, P., Oelschläger, H., Poser, W., Radke, J., Rüther, E. and Schulz, M.:
KOMBINATIONSARZNEIMITTEL AUS PARACETAMOL PLUS ACETYLSALICYLSÄURE: NUTZEN UND RISIKEN
[Fixed-dosed combinations of paracetamol(acetaminophen) and aspirin: benefits and risks].
Schmerz 1995; 9: 273–285.
1994
Schulz, M. and Schmoldt, A.:
SUCCESSFUL PHYSOSTIGMINE TREATMENT OF ACUTE DOTHIEPIN INTOXICATION.
Pharmazie 1994; 49 (8):
614.
PubMed
Scholz, J., Bause, H., Schulz, M., Klotz, U., Krishna, D.R., Pohl, S. and Schulte am Esch,
J.:
PHARMACOKINETICS AND EFFECTS ON INTRACRANIAL PRESSURE OF SUFENTANIL IN HEAD TRAUMA PATIENTS.
Br. J.
Clin. Pharmacol. 1994; 38 (4): 369–372.
PubMed
Schulz, M. and Schmoldt, A.:
ZUSAMMENSTELLUNG THERAPEUTISCHER UND TOXISCHER PLASMAKONZENTRATIONSBEREICHE VON ARZNEISTOFFEN
[Therapeutic and toxic plasma concentrations: a compilation].
Anaesthesist 1994; 43 (12):
835–844.
PubMed
1993
Schulz, M. and Schmoldt, A.:
NON-INTERACTION OF RANITIDINE WITH HYDROXYLATION OF DICLOFENAC IN RAT AND HUMAN LIVER MICROSOMES.
Pharmazie 1993; 48 (8): 625–626.
PubMed
1992
Schulz, M. and Schmoldt, A.:
KONZENTRATIONEN VON CEFOTIAM IM KOLONGEWEBE UND PLASMA NACH APPLIKATION ZUR PERIOPERATIVEN ANTIBIOTIKA-PROPHYLAXE
[Concentrations of cefotiam in colon tissue and plasma after application for perioperative antibiotic prophylaxis].
Zeitschr.
Antimikrobiol. Antineoplast. Chemother. 1992; 10: 33–37.
1991
Schulz, M., Wischhusen, F. and Schmoldt, A.:
THERAPEUTISCHE UND TOXISCHE PLASMAKONZENTRATIONEN SOWIE ELIMINATIONSHALBWERTSZEITEN GEBRÄUCHLICHER ARZNEISTOFFE.
Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1991; 26 (1): 37–43.
PubMed
Schulz, M. and Schmoldt, A.: Pharm. Ztg.
Wiss. 1991; 136 (4): 87–94 [extended reprint].
1989
Donn, F.,
Bruns, T., von Meyerinck, L., Schulz, M., Becker, W.-M., Becker, H. and Klosterhalfen, H.:
MONOCLONAL ANTIBODY THAT DEFINES THE PROSTATE SPECIFIC ANTIGEN.
Prostate 1989; 14 (3): 237–249.
PubMed
Schulz, M.,
Meyer, W., Schmitz, W., Scholz, J. and Schmoldt, A.:
BETA-REZEPTORENBLOCKER: GRUNDLAGEN ZUR ARZNEIMITTELAUSWAHL FÜR EINE RATIONALE THERAPIE
[Beta receptor blockers. Principles for drug selection for rational therapy].
Med. Monatsschr. Pharm.
1989; 12 (8): 237–244.
PubMed
Reprint in: Arzneimittelther. 1989; 7 (6): 169–176.
Schulz, M. and
Schmoldt, A.:
DETERMINATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN HUMAN PLASMA BY HIGH-PERFORMANCE
LIQUID CHROMATOGRAPHY.
Pharm. Ztg. Wiss. 1989; 134 (2): 41–44.
1988
Frese, J.H., Rohland, L., Schulz, M. and Schmoldt, A.:
INTOXIKATION MIT GALLOPAMIL. Verlauf und Therapie
[Gallopamil poisoning. Its course and therapy].
Dtsch. Med. Wochenschr.
1988; 113 (19): 770–772.
PubMed
Schulz, M.:
INTERAKTIONEN AUSGEWÄHLTER HISTAMIN H2-REZEPTORANTAGONISTEN MIT DEM
CYTOCHROM P-450-SYSTEM UND MÖGLICHE AUSWIRKUNGEN AUF DIE PHARMAKO-
KINETIK NICHTSTEROIDALER ANTIRHEUMATIKA.
[Interactions of selected histamine H2-receptor antagonists with the
cytochrome P-450 system and potential effects on the pharmacokinetics of non-steroidal antiinflammatory drugs].
PhD thesis (Dr. rer. nat.). University Hamburg. August 1988.
Schulz, M.,
Schmoldt, A., Donn, F. and Becker, H.:
THE PHARMACOKINETICS OF FLUTAMIDE AND ITS MAJOR METABOLITES AFTER A SINGLE ORAL DOSE AND DURING CHRONIC TREATMENT.
Eur. J. Clin. Pharmacol. 1988; 34 (6): 633–636.
PubMed
Schulz, M. and Schmoldt, A.:
ON THE SULPHOXIDATION OF CIMETIDINE AND ETINTIDINE BY RAT AND HUMAN LIVER MICROSOMES.
Xenobiotica 1988; 18
(8): 983–989.
PubMed
1987
Schulz, M. and Schmoldt, A.:
INTERACTIONS OF THE HISTAMINE H2-RECEPTOR ANTAGONIST ETINTIDINE WITH RAT LIVER CYTOCHROME P-450:
A COMPARISON WITH CIMETIDINE.
Naunyn-Schmiedeberg's Arch. Pharmacol. 1987; 336 (4): 453–458.
PubMed